Middle East and Africa miRNA Sequencing and Assay Market

Market Introduction

miRNA is a small noncoding RNA molecule of 20-30 nucleotides and play an important role in gene regulation. miRNA is partially complementary to messenger RNA (mRNA) and its main function is to downregulate gene expression. Since their discovery they have emerged as vital regulators of important cellular functions. miRNAs are associated with pathological processes such as viral infections, autoimmune diseases, and carcinogenesis.

Middle East and Africa miRNA Sequencing and Assay Strategic Insights

Strategic insights for the Middle East and Africa miRNA Sequencing and Assay provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East and Africa miRNA Sequencing and Assay Report Scope

Middle East and Africa miRNA Sequencing and Assay Regional Insights

The geographic scope of the Middle East and Africa miRNA Sequencing and Assay refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The Middle East and Africa miRNA sequencing and assay market is expected to reach US$ 22.00 million by 2027 from US$ 8.71 million in 2019; it is estimated to grow at a CAGR of 12.4% from 2020 to 2027. The widening application range of microRNAs and rise in funding for genomics research. However, challenges associated with the delivery, efficacy, and specificity of miRNA-based therapeutics hinder the market growth.

miRNA being involved in the process of differentiation; they play a crucial role as a useful marker in identifying cell types. miRNAs are associated with pathological processes such as viral infections, autoimmune diseases, and carcinogenesis. Thus, there is extensive research being conducted to identify new miRNAs. Furthermore, discovery regarding the role of miRNAs in disease development have made miRNAs a key target of novel therapeutic approaches. Several miRNA-targeted therapeutics against the diseases such as cancer and hepatitis have reached the clinical phase. For instance, Santaris Pharma has developed a therapeutic molecule named Miravirsen that targets miR-122 for the treatment of hepatitis C virus (HCV) infection; the molecule is in the Phase II clinical trial. Therefore, the growing range of applications of miRNAs is driving the growth of the miRNA sequencing and assay market. Similarly, rise in funding of genomic research to identify new molecules to diagnose and treat diseases across Middle East and Africa, is fuelling the market growth.

Countries in the Middle East regions are experiencing serious effects of the COVID-19 pandemic. The initial phases of lockdown in various countries affected the supply of many instruments and consumables in these regions. Due to surging COVID-19 cases, demand for novel diagnostic tests is on rise in the Middle East, and research activities have resulted in higher adoption of miRNA sequencing and assay procedures in this region. Hence, the ongoing pandemic is positively impacting the miRNA sequencing and assay market in the Middle East and Africa.

Key Market Segments

The Middle East and Africa miRNA sequencing and assay market, by product, is segmented into library preparation and consumables. The consumables segment held a larger share of the market in 2019, whereas the library preparation segment is anticipated to register a higher CAGR in the market during the forecast period.

Based on technology, the Middle East and Africa miRNA sequencing and assay market is segmented into sequencing by synthesis, nanopore, and ion semiconductor sequencing. The sequencing by synthesis segment held the largest share of the market in 2019; however, the nanopore segment is expected to register the highest CAGR in the market during 2020–2027.

Based on end user, the Middle East and Africa miRNA sequencing and assay market is segmented into research institute, academia, and CROs. The research institute segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the period.

Major Sources and Companies Listed

Some of the primary and secondary sources associated with this report on the Middle East and Africa miRNA sequencing and assay market are the the Institute for Research in Genetic Engineering and Molecular Biology (INGEBI), World Health Organization (WHO), and International Agency for Research on Cancer (IARC).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis Middle East and Africa miRNA Sequencing and Assay Market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the Middle East and Africa miRNA Sequencing and Assay Market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within Middle East and Africa miRNA Sequencing and Assay Market.

Middle East and Africa miRNA Sequencing and Assay Market Segmentation

By Product

• Library Preparation
• Consumables

By Technology

• Sequencing by Synthesis
• Nanopore
• Ion Semiconductor Sequencing

By End User

• Research Institute
• Academia
• CRO

By Country

• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East and Africa

Company Profiles

• Illumina, Inc
• THERMO FISHER SCIENTIFIC INC.
• QIAGEN
• Perkin Elmer, Inc.
• Takara Bio Inc.
• New England Biolabs
• Norgen Biotek Corp
• TriLink BioTechnologies Inc.
• Lexogen GmbH
• Oxford Nanopore Technologies